(Q37641366)

21 August 2017

1 reference

title

Viral-based gene delivery and regulated gene expression for targeted cancer therapy (English)

1 reference

21 August 2017

Yi Lu

1

1 reference

21 August 2017

Chikezie O Madu

series ordinal

2

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 January 2010

1 reference

Expert Opinion on Drug Delivery

21 August 2017

published in

1 reference

21 August 2017

volume

7

1 reference

21 August 2017

issue

1

1 reference

21 August 2017

page(s)

19-35

1 reference

21 August 2017

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Nonviral approaches satisfying various requirements for effective in vivo gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Immunostimulatory virotherapy using recombinant Sendai virus as a new cancer therapeutic regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Oncolytic viral therapy using reovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Oncolytic reovirus effectively targets breast cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Current development of lentiviral-mediated gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Cell proliferation, DNA repair, and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Identification of pretreatment agents to enhance adenovirus infection of bladder epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Comparative evaluation of viral, nonviral and physical methods of gene delivery to normal and transformed lung epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Molecular therapy with recombinant p53 adenovirus in an androgen-independent, metastatic human prostate cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Phase I/II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer--a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Prostate-specific antigen response and systemic T cell activation after in situ gene therapy in prostate cancer patients failing radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Lifelong elimination of hyperbilirubinemia in the Gunn rat with a single injection of helper-dependent adenoviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Phase I trial of replication-competent adenovirus-mediated suicide gene therapy combined with IMRT for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Interleukin 2 gene therapy for prostate cancer: phase I clinical trial and basic biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Gene therapy for gastric diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Prostate tissue specificity of the prostate-specific antigen promoter isolated from a patient with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Tissue-specific and hormonal regulation of human prostate-specific glandular kallikrein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Androgen induction of a human prostate-specific kallikrein, hKLK2: characterization of an androgen response element in the 5' promoter region of the gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Functional characterization of the GDEP promoter and three enhancer elements in retinoblastoma and prostate cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Osteocalcin-directed gene therapy for prostate-cancer bone metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

In vivo expression of prostate-specific adenoviral vectors in a canine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Transcriptionally regulated adenoviruses for prostate-specific gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

The promoter of the prostate-specific antigen gene contains a functional androgen responsive element

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Development of gene therapy for prostate cancer using a novel promoter of prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Development of a cancer-targeted tissue-specific promoter system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Viral mediated gene therapy for the management of metastatic thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Adenovirus-mediated tumor-specific combined gene therapy using Herpes simplex virus thymidine/ganciclovir system and murine interleukin-12 induces effective antitumor activity against medullary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Muscle creatine kinase sequence elements regulating skeletal and cardiac muscle expression in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Transgenic and tissue culture analyses of the muscle creatine kinase enhancer Trex control element in skeletal and cardiac muscle indicate differences in gene expression between muscle types

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Phase I clinical trial of locoregional administration of the oncolytic adenovirus ONYX-015 in combination with mitomycin-C, doxorubicin, and cisplatin chemotherapy in patients with advanced sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

In vivo gene therapy for prostate cancer: preclinical evaluation of two different enzyme-directed prodrug therapy systems delivered by identical adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Gene directed enzyme prodrug therapy for ovarian cancer: could GDEPT become a promising treatment against ovarian cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Gemcitabine-based chemogene therapy for pancreatic cancer using Ad-dCK::UMK GDEPT and TS/RR siRNA strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Prostate-specific suicide gene therapy using the prostate-specific membrane antigen promoter and enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Targeting HIF-1 for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

In vitro evaluation of cancer-specific NF-kappaB-CEA enhancer-promoter system for 5-fluorouracil prodrug gene therapy in colon cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Promoter selection for the cytosine deaminase suicide gene constructs in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

High mobility group box2 promoter-controlled suicide gene expression enables targeted glioblastoma treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Hypoxia- and radiation-activated Cre/loxP 'molecular switch' vectors for gene therapy of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

The human survivin promoter: a novel transcriptional targeting strategy for treatment of glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Comparative evaluation of survivin, midkine and CXCR4 promoters for transcriptional targeting of glioma gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Modulation of telomerase promoter tumor selectivity in the context of oncolytic adenoviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Telomerase-dependent oncolytic adenovirus for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Oncolytic adenovirus that overproduces ADP and replicates selectively in tumors due to hTERT promoter-regulated E4 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

An efficient targeted radiotherapy/gene therapy strategy utilising human telomerase promoters and radioastatine and harnessing radiation-mediated bystander effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Malignant pleural mesothelioma-targeted CREBBP/EP300 inhibitory protein 1 promoter system for gene therapy and virotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Construction of an MUC-1 promoter driven, conditionally replicating adenovirus that expresses the sodium iodide symporter for gene therapy of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Promoter-controlled infectivity-enhanced conditionally replicative adenoviral vectors for the treatment of gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Infectivity enhanced, cyclooxygenase-2 promoter-based conditionally replicative adenovirus for pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Clinical implications of the p53 tumor-suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

p53 and DNA polymerase alpha compete for binding to SV40 T antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Cancer selective adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

A prospective phase II trial of ONYX-015 adenovirus and chemotherapy in recurrent squamous cell carcinoma of the head and neck (the Baylor experience).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Site-directed mutagenesis studies of the hypoxia-inducible factor-1alpha DNA-binding domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Hypoxia-inducible factor-1alpha is a key regulator of metastasis in a transgenic model of cancer initiation and progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Cellular uptake of the tat protein from human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Protein transduction technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Modulation of cellular function by TAT mediated transduction of full length proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Mechanism of hypoxia-specific cytotoxicity of procaspase-3 fused with a VHL-mediated protein destruction motif of HIF-1alpha containing Pro564.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Expression patterns of erbB receptor family in normal urothelium and transitional cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Targeting of adenoviral vectors through a bispecific single-chain antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Virotherapy of ovarian cancer with polymer-cloaked adenovirus retargeted to the epidermal growth factor receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Local and systemic therapy of human prostate adenocarcinoma with the conditionally replicating herpes simplex virus vector G207.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Replication-competent retrovirus vectors for cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Oncolytic virotherapy for ovarian carcinomatosis using a replication-selective vaccinia virus armed with a yeast cytosine deaminase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Infected cell carriers: a new strategy for systemic delivery of oncolytic measles viruses in cancer virotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Systemic targeting of metastatic human breast tumor xenografts by Coxsackievirus A21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Oncolytic rat parvovirus H-1PV, a candidate for the treatment of human lymphoma: In vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

MicroRNA regulation of oncolytic herpes simplex virus-1 for selective killing of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Single-shot, multicycle suicide gene therapy by replication-competent retrovirus vectors achieves long-term survival benefit in experimental glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Second-generation replication-competent oncolytic adenovirus armed with improved suicide genes and ADP gene demonstrates greater efficacy without increased toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Suicide gene therapy of human colon carcinoma xenografts using an armed oncolytic adenovirus expressing carboxypeptidase G2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Targeting gene-virotherapy of cancer and its prosperity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Complete elimination of colorectal tumor xenograft by combined manganese superoxide dismutase with tumor necrosis factor-related apoptosis-inducing ligand gene virotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Retargeting to EGFR enhances adenovirus infection efficiency of squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Current advances and future challenges in Adenoviral vector biology and targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Adenoviral virotherapy for malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

In vivo retargeting of adenovirus type 5 to alphavbeta6 integrin results in reduced hepatotoxicity and improved tumor uptake following systemic delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Introduction--translational research trends: urologic gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Use of tissue-specific microRNA to control pathology of wild-type adenovirus without attenuation of its ability to kill cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Multiply deleted [E1, polymerase-, and pTP-] adenovirus vector persists despite deletion of the preterminal protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903419608

10.1517/17425240903419608

21 January 2018

Identifiers

DOI

1 reference

release_hbjlp6yhqbgdtd77r3pdas7uum

21 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hbjlp6yhqbgdtd77r3pdas7uum

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference